RPCI researcher receives grant to explore link between race and breast cancer

Christine Ambrosone, MD, Chair of Cancer Prevention and Control at Roswell Park Cancer Institute (RPCI), has received a grant for $165,000 from the Breast Cancer Research Foundation to study the possible link between race and the possibility of being diagnosed with aggressive breast cancers.

African-American women are more likely than European-Americans or Asians to be diagnosed with aggressive breast cancers and to have poor survival rates. It is hypothesized that robust immune/inflammatory responses evolved among Africans in response to endemic infectious diseases such as malaria. As a result, over the years the immune system in these women has been programmed to best protect the woman throughout her reproductive years. After that, the immune system becomes hyper-inflammatory, which is related to more aggressive breast cancers among African-American women.

The study will use data and samples from the Women's Circle of Health Study, an on-going case-control study of breast cancer in African-American and European-American women. It is hoped results of this study would open new areas for investigation regarding the basic biology of the relationship between immune factors and aggressive breast cancer.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Innovative urine test could improve pancreatic cancer survival rates